Hari Pujar, Ph.D., Chief Technology Officer, discusses the unique manufacturing and scale-up challenges involved with cell and gene therapy production.
Spark Therapeutics ranks fifth on a list of 20 admired Top Employers in the field.
Our region is a hotbed for gene and cell therapy innovation. How do we maximize this moment?
I’m optimistic about the future of Pompe disease, or better yet, a future without the devastating symptoms of Pompe disease.
For many of us, the term “modern medicine” is synonymous with breakthrough treatments for cancer, HIV/AIDS and other chronic diseases.